Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
ID: 350334Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350334

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-302.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Developing Novel Theory and Methods for Understanding the Genetic Architecture of Complex Human Traits" (R01 Clinical Trial Not Allowed). This initiative aims to support interdisciplinary research that enhances understanding of how genetic and non-genetic factors influence complex trait variations across individuals and populations, emphasizing the use of formal theories and large-scale datasets. The opportunity is significant for advancing knowledge in human genetic diversity and health disparities, requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research. Applications will be accepted starting January 5, 2024, with deadlines extending until January 8, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-302-Full-Announcement.html
    PAR-23-302.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), announced a funding opportunity titled "Developing Novel Theory and Methods for Understanding the Genetic Architecture of Complex Human Traits" (R01 Clinical Trial Not Allowed). The initiative seeks to advance applications that develop interdisciplinary methods to better comprehend how genetic and non-genetic factors contribute to variations in complex traits across populations. Proposals should incorporate a holistic understanding of these interactions, utilizing formal theories and large-scale datasets. Key details include the open application date of January 5, 2024, with subsequent deadlines throughout the year until January 8, 2027. Eligible applicants range from academic institutions to nonprofit organizations, and proposals should emphasize collaborative, diverse team compositions. Applicants must submit a Plan for Enhancing Diverse Perspectives (PEDP) to foster inclusivity within research. The selection process involves stringent criteria, including the project's significance, innovation, approach, and the research environment. This funding opportunity highlights NIH's commitment to understanding human genetic diversity and health disparities, requiring applicants to demonstrate rigorous methodologies and utilize data responsibly while addressing socially sensitive issues. The initiative is designed to generate impactful research capable of improving health outcomes through innovative and responsible genetic studies.
    Similar Opportunities
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Developing Novel Theory and Methods for Understanding the Genetic Architecture of Complex Human Traits" (PAR-25-255). This initiative aims to support interdisciplinary research that enhances the understanding of how genetic and non-genetic factors contribute to complex human traits, encouraging applicants to develop innovative theories and models while utilizing large-scale publicly accessible datasets. The funding opportunity is not open to clinical trials and allows for applications of up to five years, with a focus on rigorous scientific design and inclusivity through a Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the open submission date begins on January 5, 2025, with various deadlines extending through 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity aimed at developing novel theories and methods for understanding the genetic architecture of complex human traits through the R21 Exploratory/Developmental Research Grant mechanism. This initiative seeks interdisciplinary applications that address the interplay of genetic and non-genetic factors influencing trait variation, emphasizing the use of large-scale datasets and innovative approaches from various scientific fields. The grant allows for a maximum budget of $275,000 over two years, with a prohibition on clinical trials and a limit on new data generation to 20% of project costs. Interested applicants should note that proposals are due by January 7, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Exploratory/Developmental Research Grant to develop novel theories and methodologies for understanding the genetic architecture of complex human traits. The objective is to support innovative research that explores both genetic and non-genetic factors influencing trait variation across biological, social, and ecological levels, with a particular emphasis on addressing cancer disparities and employing systems epidemiology modeling. This grant allows for a budget of up to $275,000 over a two-year period, and applications are open to a diverse range of organizations, including higher education institutions and nonprofits. Interested applicants can find more information and submit their proposals by the close date of January 7, 2027, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U01 Clinical Trial Not Allowed)" aimed at enhancing the understanding of psychiatric disorders in diverse populations, particularly those of African ancestry. This initiative seeks applications for cooperative agreements that will focus on accelerating gene discovery efforts and promoting global mental health equity, addressing the existing gap in genomic studies that predominantly center on European populations. The funding is intended to support innovative research approaches that incorporate community engagement and career development for underrepresented groups, with a project period of up to five years. Interested applicants can find more details and submit inquiries via the NIH Grants Information email at grantsinfo@nih.gov, with the application deadline set for February 13, 2026.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" grant, aimed at stimulating innovative research in the implementation of genomic technologies in clinical care. This funding opportunity emphasizes addressing health disparities and requires applicants to develop a Plan for Enhancing Diverse Perspectives to ensure inclusivity in research teams and participant recruitment. The initiative seeks to explore the value of genomic data in improving clinical outcomes, identify barriers to implementation, and develop effective data-sharing methods, with approximately $2.4 million available for three awards and an additional $700,000 for one award in fiscal year 2024. Applications are due by February 12, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovation in the application of genomic information in clinical care, particularly for populations experiencing health disparities. The initiative seeks to enhance understanding of how to effectively implement and share genomic technologies across diverse communities, including racial and ethnic minorities, underserved rural populations, and sexual and gender minority groups. With an expected total funding of approximately $1.5 million for fiscal year 2024, individual project budgets may reach up to $250,000. Interested applicants must submit their proposals by February 11, 2025, and can find additional details and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that enhance understanding of genomic data applications, assess implementation methods, and identify barriers to health equity, particularly for underrepresented groups. The R03 grant mechanism supports small research projects with a maximum budget of $50,000 per year, with an estimated total funding of approximately $150,000 for two awards in fiscal year 2024. Applications must be submitted electronically by February 12, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.